Back
Liquidia 10K Form
Sell
32
LQDA
Liquidia
Last Price:
10.64
Seasonality Move:
23.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | LQDA/Liquidia Quarterly |
| 2020-05-11 | 10Q | LQDA/Liquidia Quarterly |
| 2020-03-16 | 10K | LQDA/Liquidia Annual |
| 2019-11-13 | 10Q | LQDA/Liquidia Quarterly |
| 2019-08-14 | 10Q | LQDA/Liquidia Quarterly |
| 2019-05-02 | 10Q | LQDA/Liquidia Quarterly |
Receive LQDA News And Ratings
See the #1 stock for the next 7 days that we like better than LQDA
LQDA Financial Statistics
Sales & Book Value
| Annual Sales: | $17.49M |
|---|---|
| Cash Flow: | $-23.95M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.82 |
| Price / Book: | 14.03 |
Profitability
| EPS (TTM): | -1.57000 |
|---|---|
| Net Income (TTM): | $-112.11M |
| Gross Margin: | $14.6M |
| Return on Equity: | -183.82% |
| Return on Assets: | -77.21% |
Liquidia Earnings Forecast
Key Liquidia Financial Ratios
- The Gross Profit Margin over the past 8 years for LQDA is 83.49%.
- The Selling, General & Administrative Expenses for LQDA have been equal to 255.84% of Gross Profit Margin.
- The Research & Development expenses have been 247.27% of Revenue.
- The Interest Expense is -7.99% of Operating Income.
- The Net Earning history of LQDA is -448.89% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 4 years.
Liquidia Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | LQDA |
| CUSIP: | 53635D |
| Website: | liquidia.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 6.08 |
| Quick Ratio: | 5.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |